News and Events | Page 3 | Helen & Robert Appel Alzheimer’s Disease Research Institute

Honoring Dr. Li Gan: Recipient of The Jessica M. and Natan Bibliowicz Award for Excellence in Mentoring Women Faculty

Professor in Neurodegenerative Diseases and director of the Helen and Robert Appel Alzheimer’s Disease Research Institute at Weill Cornell Medicine, received the Jessica M. And Natan Bibliowicz Award in recognition of her scientific achievements and mentorship of female faculty. As one of her mentees said, “Dr. Gan is a role model who leads with integrity, fosters collaboration and promotes excellence.”

“This award affirms the value of our collective efforts...

Celebrating Wenhui Qu's Achievement: Bright Focus Postdoctoral Fellowship Award!

Tauopathies, including Alzheimer's disease (AD), involve the abnormal accumulation of the toxic Tau protein in neurons, affecting millions of people without a cure. Our lab has pioneered modeling Tau buildup in human neurons using stem cells. This study proposes transplanting human stem cells into mouse brains to generate a novel chimera human-mouse model that develops Tau accumulation. Using this model, our research also examines how specific molecular pathways might affect the...

Sadaf Amin, PhD Promoted to Instructor in Neuroscience at WCM

We are thrilled to announce that Sadaf Amin, PhD, has been promoted to the role of Instructor in Neuroscience at WCM. This promotion is a testament to her exceptional dedication and expertise in the field.

Neuron review: sex differences

The Neuron review by Lopez-Lee and Torres et al. at Gan lab addresses how sex-specific factors influence Alzheimer's disease (AD) progression. It suggests that hormones and chromosomes may affect aging-related processes like inflammation, metabolism, and autophagy, leading to different AD patterns in men and women. By synthesizing advanced research, including single-cell RNA sequencing and omics analyses, the review highlights the significant role sex plays in AD prevalence, pathology...

Congratulations to Dr. Noah Guiberson from the Burre lab, who has received a grant jointly funded by Uplifting Athletes and the STXBP1 Foundation.

Dr. Noah Guiberson, a neuroscientist from Appel Institute, has been recognized as one of the 10 esteemed researchers awarded a $20,000 research grant at Uplifting Athletes' Young Investigator Draft. Organized by the nonprofit organization dedicated to supporting the rare disease community, Uplifting Athletes, in collaboration with the STXBP1 Foundation, the event showcased Dr. Guiberson's proposal to study STXBP1-related disorders by characterizing a novel STXBP1 missense mutant mouse...